Navigation Links
Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc.
Date:11/26/2014

BOCA RATON, Fla., Nov. 25, 2014 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has entered into a multi-product ANDA agreement with Pii (Pharmaceutics International, Inc.) (Hunt Valley, Maryland) under which Breckenridge and Pii expect to develop and commercialize several new ANDA's.  Under the terms of the agreement, Pii will develop, manufacture and supply the products, and Breckenridge will market and distribute the products under its own label.  The drugs, comprised of four unique dosage forms, and have combined U.S. market sales in excess of $1.6B, in the 12-month period ending September 30, 2014.  The multi-product agreement contemplates the submission of multiple ANDA's with Paragraph IV certifications.    

About Breckenridge:

Breckenridge Pharmaceutical, Inc. is a privately-held pharmaceutical marketing, research and development company founded in 1983 that markets a broad range of generic prescription products in many therapeutic categories.  The Breckenridge label is recognized by Wholesalers, Distributors, Chains, and Managed Care Accounts, as well as Retail Pharmacies nationwide.  The company markets over 60 products in a variety of dosage forms and therapeutic categories. To date through 2014, Breckenridge has filed 23 ANDA's with Paragraph IV patent challenges.
www.bpirx.com

About Pharmaceutics International, Inc.:

Pii (Pharmaceutics International, Inc.) is a privately held drug delivery solutions company providing dosage form development and GMP Manufacturing services to the global pharmaceutical industry. Headquartered in Hunt Valley Maryland USA with European development and manufacturing facilities in the UK, Pii offers preformulation testing, formulation development and clinical trial material and commercial manufacture of parenteral, solid, semi-solid and liquid dosage forms.
www.pharm-int.com


'/>"/>
SOURCE Breckenridge Pharmaceutical, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Breckenridge Completes Acquisition of Certain Cypress Products from Pernix Therapeutics
2. Breckenridge Enters Into Agreement to Acquire Certain Cypress Assets from Pernix Therapeutics
3. Breckenridge Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macovens Discontinuance of Certain Products
4. Breckenridge Pharmaceutical signs Letter of Intent with Welding GmbH & Co & SK Chemicals
5. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
6. Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets
7. Jazz Pharmaceuticals Announces Participation in Two Investor Conferences
8. Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants
9. Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference
10. Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market
11. Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2019)... (PRWEB) , ... March 16, 2019 , ... Oral ... are proud to announce that they are launching the JawFixers Implant Synergy Boot Camp. ... 2019. This series is designed for implant clinicians to better understand the placement of ...
(Date:3/15/2019)... ... March 15, 2019 , ... Dr. Srini Pillay , ... spent a large chunk of his career subverting ideas on creativity and the processes ... has been a hit since its original release in 2017. , Now, Pillay is ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... 100 Top Hospitals by IBM Watson Health™. This recognition spotlights the top-performing hospitals ... , “AdventHealth Wesley Chapel is committed to providing high-quality, whole person care for ...
Breaking Medicine Technology:
(Date:3/15/2019)... ... ... The National Association of Chain Drug Stores (NACDS) praises the enactment of ... Schedule VI, which will help prevent opioid abuse. Arkansas Gov. Asa Hutchinson (R) signed ... , NACDS recognizes the leadership of State Sen. Kim Hammer (R), sponsor of ...
(Date:3/15/2019)... ... March 15, 2019 , ... One of the leading causes of infertility in ... that is often characterized as confusing and enigmatic, Shady Grove Fertility, a national leader ... trying to conceive on March 19, 2019 with Dr. Naveed Khan of ...
(Date:3/14/2019)... ... March 14, 2019 , ... Reset Summer Camp, one of ... addiction, today announced the opening of their application portal for summer 2019. ... Today Show, Dr. Deborah Gilboa – popularly known as Dr. G – ...
(Date:3/14/2019)... ... March 14, 2019 , ... Cell & Gene Therapy Strategies for Successful ... March 28, 2019, 1:30 p.m. - 3:00 p.m. EDT, http://www.fdanews.com/blasubmissions , The ... gene therapy products a year. , That will only come true if sponsors ...
(Date:3/12/2019)... ... March 12, 2019 , ... As ... care teams will provide comprehensive, on-site services at the exclusive Midway medical center ... Auto Parts. The Infield Care Center will be staffed with emergency physicians and ...
Breaking Medicine News(10 mins):